Loss of ability to self-heal malaria upon taurine transporter deletion

Infection and Immunity

Volumn 78, Issue 4, 2010, Pages 1642-1649

  Delić, Denis ^a   Warskulat, Ulrich ^a   Borsch, Elena ^a   Al Qahtani, Saad ^b   Al Quraishi, Saleh ^c   Häussinger, Dieter ^a   Wunderlich, Frank ^a,c  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; TAURINE TRANSPORTER; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOPSY; BLOODSTREAM INFECTION; CAUSE OF DEATH; CONTROLLED STUDY; GENE DELETION; GENE EXPRESSION; HOMEOSTASIS; LIVER INJURY; MALARIA; MOUSE; MULTIPLE ORGAN FAILURE; NONHUMAN; PARASITEMIA; PLASMODIUM CHABAUDI; PLASMODIUM CHABAUDI INFECTION; PRIORITY JOURNAL;

AMMONIA; ANIMALS; FEMALE; INTERLEUKIN-1BETA; LIVER; MALARIA; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MULTIPLE ORGAN FAILURE; PARASITEMIA; PLASMODIUM CHABAUDI; SEQUENCE DELETION; SURVIVAL ANALYSIS; TAURINE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77950251510     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01159-09     Document Type: Article

References (60)

1. Aga, E., D. M. Katschinski, G. van Zandbergen, H. Laufs, B. Hansen, K. Müller, W. Solbach, and T. Laskay. 2002. Inhibition of the spontaneous apoptosis of neutrophil granulocytes by the intracellular parasite Leishmania major. J. Immunol. 169:898-905.
2. Aikawa, M., M. Suzuki, and Y. Gutierrez. 1980. Pathology of malaria, p. 47-102. In J. P. Kreier (ed.), Malaria, vol.2. Academic Press, New York, NY.
3. Balmer, P., J. Alexander, and R. S. Phillips. 2000. Protective immunity to erythrocytic Plasmodium chabaudi AS infection involves IFN-γ-mediated responses and a cellular infiltrate to the liver. Parasitology 121:473-482.
4. Barua, M., Y. Liu, and M. R. Quinn. 2001. Taurine chloramine inhibits inducible nitric oxide synthase and TNF-α gene expression in activated alveolar macrophages: decreased NF-κB activation and IκB kinase activity. J. Immunol. 167:2275-2281.
5. Benten, W. P. M., F. Wunderlich, R. Herrmann, and W. N. Kühn-Velten. 1993. Testosterone-induced compared with oestradiol-induced immunosuppression against Plasmodium chabaudi malaria. J. Endocrinol. 139:487-494.
6. Benten, W. P. M., F. Wunderlich, and H. Mossmann. 1992. Plasmodium chabaudi: estradiol suppresses acquiring, but not once-acquired immunity. Exp. Parasitol. 75:240-247.
7. Bouckenooghe, T., C. Remacle, and B. Reusens. 2006. Is taurine a functional nutrient? Curr. Opin. Clin. Nutr. Metab. Care 9:728-733.
8. Butterworth, R. F. 2002. Pathophysiology of hepatic encephalopathy: a new look at ammonia. Metab. Brain Dis. 17:221-227.
9. Butterworth, R. F., J. F. Giguère, J. Michaud, J. Lavoie, and G. P. Layrargues. 1987. Ammonia: key factor in the pathogenesis of hepatic encephalopathy. Neurochem. Pathol. 6:1-12.
10. Cetiner, M., G. Sener, A. O. Sehirli, E. Ekçsioǧlu- Demiralp, F. Ercan, S. Sirvanci, N. Gedik, S. Akpulat, T. Tecimer, and B. C. Yeǧen. 2005. Taurine protects against methotrexate-induced toxicity and inhibits leukocyte death. Toxicol. Appl. Pharmacol. 209:39-50.
11. Chapman, R. A., M. S. Suleiman, and Y. E. Earm. 1993. Taurine and the heart. Cardiovasc. Res. 27:358-363.
12. Chorazy, M., E. Kontny, J. Marcinkiewicz, and W. Maśliński. 2002. Taurine chloramine modulates cytokine production by human peripheral blood mononuclear cells. Amino Acids 23:407-413.
13. Doolan, D. L., C. Dobano, and J. K. Baird. 2009. Acquired immunity to malaria. Clin. Microbiol. Rev. 22:13-36.
14. Foote, S. J., R. A. Burt, T. M. Baldwin, A. Presente, A. W. Roberts, Y. L. Laural, A. M. Lew, and V. M. Marshall. 1997. Mouse loci for malariainduced mortality and the control of parasitemia. Nat. Genet. 17:380-381.
15. Fortin, A., L. R. Cardon, M. Tam, E. Skamene, M. M. Stevenson, and P. Gros. 2001. Identification of a new malaria susceptibility locus (Char4) in recombinant congenic strains of mice. Proc. Natl. Acad. Sci. U. S. A. 98: 10793-10798. (Erratum, 98:14744.)
16. Green, T. R., J. H. Fellman, A. L. Eicher, and K. L. Pratt. 1991. Antioxidant role and subcellular localization of hypotaurine and taurine in human neutrophils. Biochim. Biophys. Acta 1073:91-97.
17. Grimble, R. F. 2006. The effects of sulphur amino acid intake on immune functions in humans. J. Nutr. 136:1660S-1665S.
18. Häussinger, D., R. Kubitz, R. Reinehr, J. G. Bode, and F. Schliess. 2004. Molecular aspects of medicine: from experimental to clinical hepatology. Mol. Aspects Med. 25:221-360.
19. Häussinger, D., and F. Schliess. 2008. Pathogenetic mechanisms of hepatic encephalopathy. Gut 57:1156-1165.
20. Heller-Stilb, B., C. van Royen, K. Rascher, H. G. Hartwig, A. Huth, M. W. Seeliger, U. Warskulat, and D. Häussinger. 2002. Disruption of the taurine transporter gene (taut) leads to retinal degeneration in mice. FASEB J. 16:231-233.
21. Hernandez-Valladares, M., J. Naessens, J. P. Gibson, A. J. Musoke, S. Nagda, P. Rihet, O. K. Ole-Moi Yoi, and F. A. Iraqi. 2004. Confirmation and dissection of QTL controlling resistance to malaria in mice. Mamm. Genome 15:390-398.
22. Huxtable, R. J. 1992. Physiological actions of taurine. Physiol. Rev. 72:101-163.
23. Kasinathan, R. S., M. Föller, S. Koka, S. M. Huber, and F. Lang. 2007. Inhibition of eryptosis and intraerythrocytic growth of Plasmodium falciparum by flufenamic acid. Naunyn Schmiedebergs Arch. Pharmacol. 374:255-264.
24. Kincius, M., R. Liang, A. Nickkholgh, K. Hoffmann, C. Flechtenmacher, E. Ryschich, C. N. Gutt, M. M. Gebhard, J. Schmidt, M. W. Büchler, and P. Schemmer. 2007. Taurine protects from liver injury after warm ischemia in rats: the role of Kupffer cells. Eur. Surg. Res. 39:275-283.
25. Kochar, D. K., P. Agarwal, S. K. Kochar, R. Jain, N. Rawat, R. K. Pokharna, S. Kachhawa, and T. Srivastava. 2003. Hepatocyte dysfunction and hepatic encephalopathy in Plasmodium falciparum malaria. QJM 96:505-512.
26. Koka, S., S. M. Huber, K. M. Boini, C. Lang, M. Föller, and F. Lang. 2007. Lead decreases parasitemia and enhances survival of Plasmodium bergheiinfected mice. Biochem. Biophys. Res. Commun. 363:484-489.
27. Kruecken, J., M. A. Dkhil, J. V. Braun, R. M. Schroetel, M. El-Khadragy, P. Carmeliet, H. Mossmann, and F. Wunderlich. 2005. Testosterone suppresses protective responses of the liver to blood-stage malaria. Infect. Immun. 73:436-443.
28. Kruecken, J., L. I. Mehnert, M. A. Dkhil, M. El-Khadragy, W. P. M. Benten, H. Mossmann, and F. Wunderlich. 2005. Massive destruction of malariaparasitized red blood cells despite spleen closure. Infect. Immun. 73:6390-6398.
29. Kurz, A. K., F. Schliess, and D. Häussinger. 1998. Osmotic regulation of the heat shock response in primary hepatocytes. Hepatology 28:774-781.
30. Kwiatkowski, D. 2000. Genetic susceptibility to malaria getting complex. Curr. Opin. Genet. Dev. 10:320-324.
31. Lang, P. A., U. Warskulat, B. Heller-Stilb, D. Y. Huang, A. Grenz, S. Myssina, M. Duszenko, F. Lang, D. Häussinger, V. Vallon, and T. Wieder. 2003. Blunted apoptosis of erythrocytes from taurine transporter deficient mice. Cell. Physiol. Biochem. 13:337-346.
32. Liu, L., W. P. M. Benten, L. Wang, X. Hao, Q. Li, H. Zhang, D. Guo, Y. Wang, F. Wunderlich, and Z. Qiao. 2005. Modulation of Leishmania donovani infection and cell viability by testosterone in bone marrow-derived macrophages: signaling via surface binding sites. Steroids 70:604-614.
33. Marcinkiewicz, J., A. Grabowska, J. Bereta, K. Bryniarski, and B. Nowak. 1998. Taurine chloramine down-regulates the generation of murine neutrophil inflammatory mediators. Immunopharmacology 40:27-38.
34. Marcinkiewicz, J., M. Mak, M. Bobek, R. Biedroń, A. Białecka, M. Koprowski, E. Kontny, and W. Maśliński. 2005. Is there a role of taurine bromamine in inflammation? Interactive effects with nitrite and hydrogen peroxide. Inflamm. Res. 54:42-49.
35. Min-Oo, G., A. Fortin, G. Pitari, M. Tam, M. M. Stevenson, and P. Gros. 2007. Complex genetic control of susceptibility to malaria: positional cloning of the Char9 locus. J. Exp. Med. 204:511-524.
36. Munoz, S. J. 2008. Hepatic encephalopathy. Med. Clin. North Am. 92:795-812.
37. Neill, A. L., T. Chan-Ling, and N. H. Hunt. 1993. Comparisons between microvascular changes in cerebral and non-cerebral malaria in mice, using the retinal whole-mount technique. Parasitology 107:477-487.
38. Park, E., G. Schuller-Levis, and M. R. Quinn. 1995. Taurine chloramine inhibits production of nitric oxide and TNF-α in activated RAW 264.7 cells by mechanisms that involve transcriptional and translational events. J. Immunol. 154:4778-4784.
39. Peters-Regehr, T., J. G. Bode, R. Kubitz, and D. Häussinger. 1999. Organic osmolyte transport in quiescent and activated rat hepatic stellate cells (Ito cells). Hepatology 29:173-180.
40. Pinkerton, W., and M. Webber. 1964. A method of injecting small laboratory animals by the ophthalmic plexus route. Proc. Soc. Exp. Biol. Med. 116:959-961.
41. Roberts, C. W., W. Walker, and J. Alexander. 2001. Sex-associated hormones and immunity to protozoan parasites. Clin. Microbiol. Rev. 14: 476-488.
42. Sayles, P. C., and D. L. Wassom. 1988. Immunoregulation in murine malaria. Susceptibility of inbred mice to infection with Plasmodium yoelii depends on the dynamic interplay of host and parasite genes. J. Immunol. 141:241-248.
43. Schuller-Levis, G. B., and E. Park. 2004. Taurine and its chloramine: modulators of immunity. Neurochem. Res. 29:117-126.
44. Seabra, V., R. F. Stachlewitz, and R. G. Thurman. 1998. Taurine blunts LPS-induced increases in intracellular calcium and TNF-α production by Kupffer cells. J. Leukoc. Biol. 64:615-621.
45. Stapleton, P. P., L. O'Flaherty, H. P. Redmond, and D. J. Bouchier-Hayes. 1998. Host defense-a role for the amino acid taurine? J. Parenter. Enteral Nutr. 22:42-48.
46. Suzuki, T., T. Suzuki, T. Wada, K. Saigo, and K. Watanabe. 2002. Taurine as a constituent of mitochondrial tRNAs: new insights into the functions of taurine and human mitochondrial diseases. EMBO J. 21:6581-6589.
47. Tan, B., D. J. Jiang, H. Huang, S. J. Jia, J. L. Jiang, C. P. Hu, and Y. J. Li. 2007. Taurine protects against low-density lipoprotein-induced endothelial dysfunction by the DDAH/ADMA pathway. Vascul. Pharmacol. 46:338-345.
48. Timbrell, J. A., V. Seabra, and C. J. Waterfield. 1995. The in vivo and in vitro protective properties of taurine. Gen. Pharmacol. 26:453-462.
49. Vutova, P., M. Wirth, D. Hippe, U. Gross, K. Schulze-Osthoff, I. Schmitz, and C. G. Lüder. 2007. Toxoplasma gondii inhibits Fas/CD95-triggered cell death by inducing aberrant processing and degradation of caspase 8. Cell. Microbiol. 9:1556-1570.
50. Warskulat, U., E. Borsch, R. Reinehr, B. Heller-Stilb, I. Mönnighoff, D. Buchczyk, M. Donner, U. Flögel, G. Kappert, S. Soboll, S. Beer, K. Pfeffer, H. U. Marschall, M. Gabrielsen, M. Amiry-Moghaddam, O. P. Ottersen, H. P. Dienes, and D. Häussinger. 2006. Chronic liver disease is triggered by taurine transporter knockout in the mouse. FASEB J. 20: 574-576.
51. Warskulat, U., B. Heller-Stilb, E. Oermann, K. Zilles, H. Haas, F. Lang, and D. Häussinger. 2007. Phenotype of the taurine transporter knockout mouse. Methods Enzymol. 428:439-458.
52. Warskulat, U., F. Zhang, and D. Häussinger. 1997. Taurine is an osmolyte in rat liver macrophages (Kupffer cells). J. Hepatol. 26:1340-1347.
53. Weik, C., U. Warskulat, J. G. Bode, T. Peters-Regehr, and D. Häussinger. 1998. Compatible organic osmolytes in rat liver sinusoidal endothelial cells. Hepatology 27:569-575.
54. Welch, W. J., and C. R. Brown. 1996. Influence of molecular and chemical chaperones on protein folding. Cell Stress Chaperones 1:109-115.
55. Wendon, J., and W. Lee. 2008. Encephalopathy and cerebral edema in the setting of acute liver failure: pathogenesis and management. Neurocrit. Care 9:97-102.
56. Wettstein, M., and D. Häussinger. 1997. Cytoprotection by the osmolytes betaine and taurine in ischemia-reoxygenation injury in the perfused rat liver. Hepatology 26:1560-1566.
57. Wunderlich, F., P. Marinovski, W. P. M. Benten, H. P. Schmitt-Wrede, and H. Mossmann. 1991. Testosterone and other gonadal factor(s) restrict the efficacy of genes controlling resistance to Plasmodium chabaudi malaria. Parasite Immunol. 13:357-367.
58. Wunderlich, F., H. Mossmann, M. Helwig, and G. Schillinger. 1988. Resistance to Plasmodium chabaudi in B10 mice: influence of the H-2 complex and testosterone. Infect. Immun. 56:2400-2406.
59. Wunderlich, F., H. Stübig, and E. Königk. 1982. Development of Plasmodium chabaudi in mouse red blood cells: structural properties of the host and parasite membranes. J. Protozool. 29:60-66.
60. Zhang, F., L. Tong, H. Qiao, X. Dong, G. Qiao, H. Jiang, and X. Sun. 2008. Taurine attenuates multiple organ injury induced by intestinal ischemia reperfusion in rats. J. Surg. Res. 149:101-109.